Stay updated on Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe error page’s footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.7.0 was added to the page. A large set of study-related terms, drug names, and the list of participating institutions and investigators was removed, altering how the study is identified and linked to sites.SummaryDifference22%

- Check55 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, indicating a deployment update. No study content or eligibility details were changed.SummaryDifference0.0%

- Check62 days agoChange DetectedA funding attribution line '2018 ( U.S. NIH Grant/Contract )' was added under the study identifiers to document NIH support for the trial. This reflects funding source information rather than a change to the trial's content or procedures.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page template or system. The displayed trial information remains unchanged.SummaryDifference0.0%

Stay in the know with updates to Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.